FDA Approved: PHESGO — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved PHESGO (PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF) from Genentech under an Original Application; a fixed-dose subcutaneous combination for HE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer

Drugs mentioned

• PHESGO (PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF)

Snippet

ORIG AP for PHESGO (PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF)